Calmark Sweden AB (CALMA B) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

499.19 k

Shareholding (Jun 2023)

FII

0.00%

Held by 0 FIIs

DII

Held by 5 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Medical Specialties

Market cap

SEK 14 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.06

Return on Equity

-105.83%

Price to Book

0.34

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Dec 2023)

Net Profit:

-6 Million

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

2.66%

EBIT Growth (5y)

-238.34%

EBIT to Interest (avg)

-22.83

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.06

Sales to Capital Employed (avg)

0.00

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.34

EV to EBIT

-0.39

EV to EBITDA

-0.63

EV to Capital Employed

0.30

EV to Sales

11.56

PEG Ratio

Dividend Yield

ROCE (Latest)

-75.54%

ROE (Latest)

-105.83%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bullish

Bollinger Bands

Mildly Bearish

Sideways

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2023

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Domestic Funds

Held in 1 Schemes (4.92%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2023 is 0.00% vs -100.00% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2023 is -29.55% vs 21.43% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.60",
          "val2": "-3.70",
          "chgp": "2.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.70",
          "val2": "-4.40",
          "chgp": "-29.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-60,197.20%",
          "val2": "0.00%",
          "chgp": "-6,019.72%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 0.00% vs -50.00% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 53.94% vs -117.12% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-18.20",
          "val2": "-30.00",
          "chgp": "39.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-8.00",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-22.20",
          "val2": "-48.20",
          "chgp": "53.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-153,279.40%",
          "val2": "-544,666.70%",
          "chgp": "39,138.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'23 - QoQ

Dec'23

Sep'23

Change(%)

Net Sales

0.10

0.00

Operating Profit (PBDIT) excl Other Income

-3.60

-3.70

2.70%

Interest

1.40

0.00

Exceptional Items

0.00

Consolidate Net Profit

-5.70

-4.40

-29.55%

Operating Profit Margin (Excl OI)

-60,197.20%

0.00%

-6,019.72%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2023 is 0.00% vs -100.00% in Sep 2023

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2023 is -29.55% vs 21.43% in Sep 2023

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

0.10

Operating Profit (PBDIT) excl Other Income

-18.20

-30.00

39.33%

Interest

1.40

0.00

Exceptional Items

0.00

-8.00

100.00%

Consolidate Net Profit

-22.20

-48.20

53.94%

Operating Profit Margin (Excl OI)

-153,279.40%

-544,666.70%

39,138.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is 0.00% vs -50.00% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 53.94% vs -117.12% in Dec 2022

All Annual Results

Company CV

About Calmark Sweden AB

Calmark Sweden AB

Medical Specialties

Calmark Sweden AB is a Sweden-based Company providing patient-near-term testing (PNA) specialized in newborns. Its main focus is to develop medical diagnostic biotechnology. The Company focuses on the development of solutions for point-of-care detection of critical illness. Calmark Sweden AB supports physicians and other healthcare professionals to detect illness independently of the cause and regardless of the symptoms.

Company Coordinates

Company Details

Sommargatan 101A , KARLSTAD None : 656 37

Tel:

https://www.calmark.se/

Registrar Details